You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2026 › February › 09
Nordisk
5 months ago
Novo is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe patents, and is seeking to recover damages.
Novo Nordisk pops 8% after Hims & Hers pulls copycat weight-loss pill ⊕
Novo Nordisk shares jumped 8% Monday after Hims & Hers said it will pull its copycat weight-loss pill off the market.
page 1 of 1